Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) in Q4 CY2024, but sales fell by 3.8% year on year to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jan. 21, 2025 — Parents attending an adult weight management program, who were worried about their child's weight, would accept support and signposting to services ... While Most Americans Use a ...

Dec. 11, 2024 — Researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the ... AI-Powered Blood Test First to ...

I've been a Cigna Global Health Insurance policyholder for seven years and had never filed a claim until recently. A few weeks ago, I had to undergo a surgical procedure. I first contacted Cigna ...